03-7407. Office of the Director, National Institutes of Health; Notice of Meeting  

  • Start Preamble

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. appendix 2), notice Start Printed Page 15211is hereby given of a meeting of the Director's Council of Public Representatives.

    The meeting will be open to the public, with attendance limited to space availale. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting.

    Name of Committee: Director's Council of Public Representatives.

    Date: April 24, 2003.

    Time: 8:30 a.m. to 4:30 pm.

    Agenda: Among the topics proposed for discussion are: (1) The NIH Director's Report; (2) update on the NIH Director's Road Map Initiative; (3) update on the Government Performance and Results Act (GPRA) implemenation; and (4) update on the NIH Communications Plan.

    Place: National Institutes of Health, Building 31, C Wing, Conference Room 6, 9000 Rockville Pike, Bethesda, MD 20892.

    Contact Person: Jennifer E. Gorman Vetter, NIH Public Liaison/COPR Coordinator, Office of Communications and Public Liaison, Office of the Director, National Institutes of Health, 9000 Rockville Pike, Building 1, Room 344, Bethesda, MD 20892, (301) 435-4448, gormanj@od.nih.gov.

    In the interest of security, NIH has instituted stringent procedures for entrance into the building by non-government employees. Persons without a government I.D. will need to show a photo I.D. and sign-in at the security desk upon entering the building.

    Information is also available on the Institute's/Center's Home Page: http://www.nih.gov/​about/​publicliaison/​index.html,, where an agenda and any additional information for the meeting will be posted when available.

    Start Signature

    (Catalogue of Federal Domestic Assistance Program Nos. 93.14, Intramural Research Award; 93.187, Undergraduate Scholarship Program for Individuals from Disadvantaged Backgrounds; 93.22, Clinical Research Loan Repayment Program for Individuals from Disadvantaged Background; 93.232, Loan Repayment Program for Research Generally; 93.39, Academic Research Enhancement Award; 93.936, NIH Acquired Immunodeficiency Syndrome Research Loan Repayment Program, National Institutes of Health, HHS)

    Dated: March 20, 2003.

    LaVerne Y. Stringfield,

    Director, Office of Federal Advisory Committee Policy.

    End Signature End Preamble

    [FR Doc. 03-7407 Filed 3-27-03; 8:45 am]

    BILLING CODE 4140-01-M

Document Information

Effective Date:
4/24/2003
Published:
03/28/2003
Department:
National Institutes of Health
Entry Type:
Notice
Document Number:
03-7407
Dates:
April 24, 2003.
Pages:
15210-15211 (2 pages)
PDF File:
03-7407.pdf